Recent research has found testosterone therapy drugs may cause an increased risk of stroke, heart attacks, and serious clots, leading to serious physical injuries and death. These injuries are the subject of testosterone litigation as thousands of men report injuries after beginning treatment.
Also referred to as Low-T treatment, testosterone therapy is prescribed to men to fight the body’s decline in testosterone as they age. As stated in the video, one of the more common testosterone supplements advertised on TV is AndroGel. AndroGel is made by Abbott Laboratories (now AbbVie Inc.) and amounts to about 50% of the testosterone market.
Other prescribed testosterone replacement therapies include Androdern, Axirom, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim, and Testopel. Last year alone there were 5 to 6 million prescriptions for testosterone therapy drugs prescribed to men in the United States.
Despite the risks of testosterone supplements dramatically increasing the likelihood of stroke or heart attack, and through aggressive advertising, low T treatment has become a multibillion-dollar market for giant pharmaceutical companies such as AbbVie Inc. and Eli Lilly.
Testosterone Litigation is Underway
Testosterone therapy lawsuits are being investigated involving the above testosterone products. If you or someone you love suffered a serious injury while undergoing testosterone therapy, you may have a claim against the manufacturer. Our defective drug lawyers can help you pursue the compensation you deserve.
Side effects of testosterone replacement therapy include:
- Heart attack
- Stroke
- Pulmonary embolism
- Deep Vein Thrombosis
- Other serious blood clots
- Death
